by Joel Rothman | Feb 10, 2009 | NutriSupLaw
What do sibutramine, rimonabant, phenytoin and phenolphthalein have in common? You can find them spread among the 69 brands of weight-loss pills identified by the FDA. The weight-loss segment of the industry will likely see even more scrutiny of its manufacturing...
by Joel Rothman | Jan 19, 2009 | NutriSupLaw
Or is it? A recent article in the Wall Street Journal cites several sources that say many of the health claims are exaggerated. The bacteria either don’t do the job or the research is lacking to prove the claim. Consumer beware, warns the Journal. Manufacturer...
by Joel Rothman | Jan 18, 2009 | NutriSupLaw
In the conclusion to the FTC’s follow-up action against Kevin Trudeau for making deceptive claims about his books, a federal judge has ordered Trudeau to pay more than $37 million for violating a 2004 stipulated order by misrepresenting the content of his book,...
by Joel Rothman | Jan 18, 2009 | NutriSupLaw
Back in September we reported on FTC action against companies allegedly selling bogus cancer cures. To read our original post, click here. The FTC press release page on this matter lists the actions and contains links to the case files for each. Among the cases is...
by Joel Rothman | Jan 15, 2009 | NutriSupLaw
The Center for Science in the Public Interest (CSPI) has filed suit against Coke and Energy Brands claiming that the companies make deceptive and unsubstantiated claims on the VitaminWater line of beverages. To read the press release, click here. Coke markets...
